Epilepsy

Common presentations between epilepsy and syncope complicate the differential diagnosis, making syncope the most frequent misdiagnosis in epilepsy.

Researchers evaluated several databases to determine whether or not depression has a causative role on epilepsy, or vice versa.

Ten general and disease-specific apps for neurologists include assessment scales, anatomical diagrams, and interactive clinical decision support.

February news includes stroke risk with Alzheimer disease & migraine, neonatal hemorrhagic stroke, and head trauma in sports.

Stroke is the most common cause of epilepsy in older adults, but there is limited information about rates and risk factors in this population.

Previous studies of methylphenidate in epilepsy patients have suffered from small numbers and methodological issues, such as lack of blinding.

January news includes the first FDA-approved drug for spinal muscular atrophy, various epilepsy treatments & vitamin D’s impact on Alzheimer & headache.

Orthostatic hypotension’s effect on cognition in Parkinson disease, testing patients with epilepsy who can drive safely, and carotid web are covered.

Research from AES 2016 explored relationships between epilepsy and other neurological disorders, including Alzheimer disease, MS, stroke, and autism.

November news includes the first human clinical trial focusing on tau in Alzheimer disease and Zika-related microcephaly not presenting at birth.

Tumor-related epilepsy is poorly controlled by antiepileptic drugs, and the best management of tumor-related focal epilepsies remains controversial.

Case 1 (of 4): Increasingly disruptive behavior and possible deteriorating cognitive function in a young girl with a previous right hemispherectomy.

After failed drug interventions, surgeries, & alternative therapies, is there a point at which to stop additional treatments for intractable epilepsy?

Antiepileptic drugs, insomnia, and obstructive sleep apnea may all affect the already complicated relationship between epilepsy and sleep.

Leading epilepsy researchers speculated on trends in surgery & devices, imaging, medication, bioinformatics, and genetic discoveries.

To improve understanding, Lara Marcuse, MD called for a unified definition of seizure clusters during Epilepsy Therapies Symposium: Risky Business.

Award-winning basic, translational, or clinical epilepsy research covered cannabidiol treatment, outcome predictions, imaging studies, and more.

AES President Emeritus Dr. Elson So covered discussing SUDEP with your patients & their families and reviewed current and future research highlights.

Careful planning and monitoring is important for women with epilepsy who become pregnant. Several studies from AES 2016 address pregnancy issues.

Up to 45% of stroke victims over the age of 60 will develop epilepsy. Researchers at AES 2016 presented risk factors of post-stroke epilepsy.

From surgical procedure selection to multiscale imaging to use of the latest drugs, we present a list of 10 not-to-be-missed sessions at AES 2016.

November news includes potential Alzheimer treatments, FDA approval of a device to prevent recurrent stroke, & a newly typified headache disorder.

Researchers evaluated cognitive and motor development, receptive language, and memory in 214 children who had experienced febrile status epilepticus.

Although tremendous advances in research and medical ethics have been made since the mid-20th century, questions continue.

Oct. news includes an approved deep brain stimulation system for movement disorders & biomarkers that improve risk assessment in atrial fibrillation.